Adenocarcinoma/genetics/metabolism/pathology; Animals; Carcinoma, Non-Small-Cell Lung/genetics/metabolism/pathology; Cell Movement; Cell Transformation, Neoplastic/genetics/metabolism/pathology; Electron Transport Complex I/genetics/metabolism; Gene Expression Regulation, Neoplastic; Genome, Mitochondrial; Humans; Lung Neoplasms/genetics/metabolism/pathology; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria/genetics/metabolism/pathology; Neoplasm Invasiveness; Oxidative Stress; Proto-Oncogene Proteins c-mdm2/genetics/metabolism; Signal Transduction; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53/genetics/metabolism; Xenograft Model Antitumor Assays; MDM2; MT-ND6; hypoxia; migration; mitochondria; respiratory complex I
Abstract :
[en] Accumulating evidence indicates that the MDM2 oncoprotein promotes tumorigenesis beyond its canonical negative effects on the p53 tumor suppressor, but these p53-independent functions remain poorly understood. Here, we show that a fraction of endogenous MDM2 is actively imported in mitochondria to control respiration and mitochondrial dynamics independently of p53. Mitochondrial MDM2 represses the transcription of NADH-dehydrogenase 6 (MT-ND6) in vitro and in vivo, impinging on respiratory complex I activity and enhancing mitochondrial ROS production. Recruitment of MDM2 to mitochondria increases during oxidative stress and hypoxia. Accordingly, mice lacking MDM2 in skeletal muscles exhibit higher MT-ND6 levels, enhanced complex I activity, and increased muscular endurance in mild hypoxic conditions. Furthermore, increased mitochondrial MDM2 levels enhance the migratory and invasive properties of cancer cells. Collectively, these data uncover a previously unsuspected function of the MDM2 oncoprotein in mitochondria that play critical roles in skeletal muscle physiology and may contribute to tumor progression.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
ARENA, Giuseppe ; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier F-34298, France